Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Headshot of Dr. Richard F. Little

Richard F. Little, M.D.

Head of Hematologic, HIV, and Stem Cell Therapeutics
NCI DCTD - Cancer Therapy Evaluation Program
Clinical Investigations Branch
240-276-6560
|
littler@mail.nih.gov

Dr. Richard F. Little came to NIH in 1992 and joined CTEP in 2007 as head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell Transplant. His focus is to oversee, review, and coordinate the NCI-sponsored late phase cancer treatment trials in these diseases. Dr. Little serves as lead CTEP reviewer for MyeloMATCH, a portfolio of AML and MDS trials that uses advanced assays to target residual disease with increasing precision as newly diagnosed patients undergo treatment, and for other precision medicine initiatives, including MATCH and ComboMATCH.

Dr. Little received his medical degree from the University of South Carolina in 1989. After completing Residency Training in Internal Medicine at the Boston City Hospital, he completed a combined medical oncology and hematology fellowship in 1994 at the National Heart Lung and Blood Institute and the National Cancer Institute. Dr. Little was recognized as an outstanding teacher and mentor in 2005 when he was nominated for the Distinguished NIH Teacher award.

  • Updated:
Email